We have a broad and differentiated pipeline of investigational drugs across our family of companies.
We have run numerous large successful international Phase 3 clinical trials.
Agnostic to therapeutic area and modality
Our pipeline includes innovative product candidates across numerous therapeutic areas including immunology, oncology, hematology, and dermatology.
Interested in learning more?
Discover how our model aligns incentives to drive fast, high-quality execution and rigorous capital allocation.
Nimble, entrepreneurial Vants
Explore our diverse family of biopharmaceutical and health technology companies.